KALA BIO, Inc.SEC Filings
|
|
All SEC filings by KALA BIO, Inc. (KALA) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 19, 2026 | |
| NT 10-Q | Notice of late quarterly filing | Aug 14, 2026 | ||
| 10-Q | Quarterly report | View Diff | May 15, 2026 | |
| 10-K | Annual report | View Diff | Apr 15, 2026 | |
| NT 10-K | Notice of late annual filing | Mar 31, 2026 | ||
| 10-Q | Quarterly report | View Diff | Nov 19, 2025 | |
| NT 10-Q | Notice of late quarterly filing | Nov 14, 2025 | ||
| 10-Q | Quarterly report | View Diff | Aug 8, 2025 | |
| 10-Q | Quarterly report | View Diff | May 14, 2025 | |
| 10-K | Annual report | View Diff | Mar 31, 2025 |
Events
| 8-K | Current report | Sep 10, 2026 | ||
| 8-K | Current report | Sep 9, 2026 | ||
| 8-K | Current report | Aug 28, 2026 | ||
| 8-K | Current report | Jul 22, 2026 | ||
| 8-K | Kala Bio Announces Reverse Stock Split | May 7, 2026 | ||
| 8-K | Kala Bio Announces Strategic Initiative to Deploy and Continue to Develop An | Mar 4, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Feb 20, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Feb 5, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | Feb 2, 2026 | ||
| 8-K | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard | Jan 23, 2026 |
Registrations and Prospectuses
| 424B5 | Prospectus supplement for primary offering | Jul 22, 2026 | ||
| S-3/A | Shelf registration | View Diff | Jun 12, 2026 | |
| S-3 | Shelf registration | View Diff | May 7, 2026 | |
| D | $1,753,500 in Equity — 1 Investor | Mar 17, 2026 | ||
| 424B3 | Prospectus supplement | Feb 17, 2026 | ||
| D | $4,200,000 in Equity — 20 Investors | Feb 12, 2026 | ||
| S-3 | Shelf registration | View Diff | Feb 9, 2026 | |
| 424B5 | Prospectus supplement for primary offering | Jan 8, 2026 | ||
| 424B5 | Prospectus supplement for primary offering | Dec 5, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | Mar 31, 2025 |
Proxies
| DEF 14A | Annual Meeting of Shareholders | View Diff | Sep 24, 2026 | |
| PRE 14A | Annual Meeting of Shareholders | View Diff | Sep 11, 2026 | |
| DEFA14A | Annual Meeting of Shareholders | Jan 26, 2026 | ||
| DEFA14A | Annual Meeting of Shareholders | Jan 6, 2026 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Dec 30, 2025 | |
| PRER14A | Preliminary revised proxy | Dec 19, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | May 30, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 29, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 29, 2024 | |
| PRE 14A | Preliminary proxy | View Diff | Apr 19, 2024 |
Other
| EFFECT | Notice of effectiveness | Jun 26, 2026 | ||
| EFFECT | Notice of effectiveness | Feb 18, 2026 | ||
| CORRESP | Correspondence with SEC | Feb 13, 2026 | ||
| UPLOAD | Letter from SEC | Feb 13, 2026 | ||
| EFFECT | Notice of effectiveness | Feb 5, 2025 | ||
| CORRESP | Correspondence with SEC | Jan 31, 2025 | ||
| UPLOAD | Letter from SEC | Jan 31, 2025 | ||
| EFFECT | Notice of effectiveness | Aug 1, 2024 | ||
| CORRESP | Correspondence with SEC | Jul 29, 2024 | ||
| UPLOAD | Letter from SEC | Jul 26, 2024 |
Ownership
| SC 13D/A | Lazar David E. Updates Stake in Kala Bio, Inc. | Jul 2, 2026 | ||
| SC 13G/A | Baker Bros. Advisors Lp Updates Stake in Kala Bio, Inc. | May 15, 2026 | ||
| 144 | Notice of proposed sale of securities | Mar 17, 2026 | ||
| 144 | Notice of proposed sale of securities | Mar 12, 2026 | ||
| 144 | Notice of proposed sale of securities | Mar 12, 2026 | ||
| SC 13G/A | Baker Bros. Advisors Lp Updates Stake in Kala Bio, Inc. | Feb 17, 2026 | ||
| 3 | Brendan P. Purdy | Feb 9, 2026 | ||
| 3 | Hillel D. Posen | Feb 9, 2026 | ||
| 3 | Avraham Minkowitz | Feb 9, 2026 | ||
| 3 | Yonatan C. Colman | Feb 9, 2026 |